Canada Establishes Standing Offer for NARCAN® Distribution with Emergent BioSolutions
The Government of Canada has awarded Emergent BioSolutions a standing offer contract for NARCAN® Nasal Spray, effective from October 1, 2026, through September 30, 2029. This contract allows various public sector organizations to procure the vital opioid overdose reversal medication, underlining the government's commitment to combating the opioid crisis.
Key Signals
- Emergent BioSolutions awarded multi-year standing offer for NARCAN® Nasal Spray
- Contract effective from October 1, 2026, through September 30, 2029
- Authorized public sector organizations can procure NARCAN® via individual call-ups
In a significant step towards battling the opioid crisis, the Government of Canada has awarded Emergent BioSolutions a standing offer contract to supply NARCAN® Nasal Spray across the country. This contract, set to begin on October 1, 2026, and extending through September 30, 2029, comes with an option for a two-year extension. The aim of this initiative is to ensure that federal, provincial, territorial, and other public sector organizations have immediate access to a critical tool in combating opioid overdoses, a pressing public health issue in Canada.
NARCAN® is a widely recognized opioid antagonist that can help reverse the effects of opioid overdoses. By granting this contract, the Government of Canada signals its commitment to enhancing public health measures and ensuring that lifesaving medications are readily available to those in need. The standing offer model allows for individual call-ups by various authorized entities, thereby facilitating quick and efficient procurement of the medication, which is essential for emergency responses to overdose incidents.
This procurement decision aligns with broader public health initiatives aimed at addressing the escalating opioid crisis in Canada. The opioid epidemic has reached alarming levels, leading to a surge in overdose deaths. By improving access to NARCAN®, the Canadian government is taking decisive action to mitigate the impact of this crisis on communities across the nation. As part of this initiative, public health agencies are expected to engage in coordinated efforts that may enhance inventory management and response capabilities at the local and regional levels.
Procurement professionals in the pharmaceutical and medical supply sectors should take note of this opportunity. The multi-year nature of the standing offer presents various business possibilities, including logistics, distribution, and support services that align with this critical need. Moreover, as the contract encompasses all authorized public sector organizations—including provinces and territories—it reflects a broad market potential for suppliers and distributors who can meet the requirements set forth by the contract.
Agencies
- Government of Canada
Vendors
- Emergent BioSolutions
Sources
- Emergent BioSolutions Wins Canada NARCAN Offer | EBS Stock NewsStock Titan · Aug 31